Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets
Ben VezinaiD, Guillaume A. PetitiD, Jennifer L. MartiniD, Maria A. HaliliiD
Abstract
Identification of bacterial virulence factors is critical for understanding disease pathogenesis, drug discovery and vaccine development. In this study we used two approaches to predict virulence factors of Burkholderia pseudomallei, the Gram-negative bacterium that causes melioidosis. B. pseudomallei is naturally antibiotic resistant and there are no melioidosis vaccines. To identify B. pseudomallei protein targets for drug discovery and vaccine development, we chose to search for substrates of the B. pseudomallei periplasmic disulfide bond forming protein A (DsbA). DsbA introduces disulfide bonds into extra-cytoplasmic proteins and is essential for virulence in many Gram-negative organism, including B. pseudomallei. The first approach to identify B. pseudomallei DsbA virulence factor substrates was a large-scale genomic analysis of 511 unique B. pseudomallei disease-associated strains. This yielded 4,496 core gene products, of which we hypothesise 263 are DsbA substrates. Manual curation of the 263 mature proteins yielded 73 associated with disease pathogenesis or virulence. These were screened for structural homologues to predict potential B-cell epitopes. In the second approach, we searched the B. pseudomallei genome for homologues of the more than 90 known DsbA substrates in other bacteria. Using this approach, we identified 15 potential B. pseudomallei DsbA virulence factor substrates. Two putative B. pseudomallei virulence factors were identified by both methods: homologues of PenI family β-lactamase and of succinate dehydrogenase flavoprotein subunit. These two proteins could serve as high priority targets for future B. pseudomallei virulence factor characterization.Competing Interest StatementThe authors have declared no competing interest.View Full Text
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 0.72
- Field percentile
- top 29%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification and characterization of two drug-like fragments that bind to the same cryptic binding pocket of Burkholderia pseudomallei DsbA
Guillaume A. Petit, Biswarajan Mohanty, … Maria A. Halili·Acta Crystallographica Section D Structural BiologyPeer-reviewed·Dec 22, 2021
- Designing a novel Scaffold-Based Multi-Epitope Vaccine to Combat Melioidosis Caused by Burkholderia pseudomallei: An In-silico and Immunoinformatics approach
Shakilur Rahman, Ardhendu Das, … Amlan Roychowdhury·bioRxiv·Jun 18, 2024
- Subtractive proteomics unravel the potency of D-Alanine-D-Alanine Ligase as the drug target for Burkholderia pseudomallei
Shakilur Rahman, Ayush Bhattacharya, … Amlan Roychowdhury·bioRxiv·Oct 15, 2024
- Immunological Patterns from Four Melioidosis Cases: Constant and Variable Protein Antigens
Jinhee Yi, Kelsey Herring, … Paul Keim·bioRxiv·Nov 20, 2016
- In silico identification of metabolic enzyme drug targets in Burkholderia pseudomallei
Jean F. Challacombe·bioRxiv·Dec 20, 2017
- Raising the stakes: Loss of efflux-pump regulation decreases meropenem susceptibility in Burkholderia pseudomallei
D. S. Sarovich, J. R. Webb, … E. P. Price·bioRxiv·Oct 20, 2017